Financial Services - Business Development Companies / Alternative Credit
Strategic Profile
CIM's rigorous investment process and target deal size allows CION to be highly selective and close deals with favorable terms. The fund does not invest in start-up companies, turnaround situations, or companies with speculative business plans. CION maintains a diversified portfolio across high-tech, healthcare, pharmaceuticals, and industrial sectors.
Cyborg Score Rationale
CION Investment Corporation faces significant financial headwinds, with declining NAV, shrinking portfolio, and rising leverage compared to peers. CION Investment Corp faces significant headwinds, including declining earnings, a rising non-accrual rate, and trades at a deep discount to NAV. However, recent Q3 2025 earnings exceeded expectations with strong revenue and net income.
Top Insights
In 2024, CION Investment's revenue was $252.43 million, an increase of 0.57% compared to the previous year's $251.01 million.
CION runs higher leverage than peers and faces a 2027 maturity wall.
CION earnings for the last quarter are 0.74 USD per share, whereas the estimation was 0.33 USD resulting in a 122.00% surprise.
According to one analyst, the rating for CION stock is "Sell" and the 12-month stock price target is $8.5.
Named Competitors
Blackstone BDC — Large-scale BDC focusing on private credit
Golub Capital — Alternative asset manager specializing in middle-market credit
Gladstone Capital — BDC providing debt and equity investments to small/mid-market companies
Recent Developments
(Feb 2026) Base distributions declared of $0.10 per share for Jan, Feb, and Mar 2026
(Dec 2025) Closed offering of $172.5 million in senior unsecured notes